Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 15, 2011

Premium

Agendia last week made three appointments to its executive team. David Macdonald has been named chief operating officer, Mark Willig has been tapped to be executive vice president of North American sales, and Doug Bradley has been appointed vice president of global marketing.

Macdonald has been involved in commercializing clinical diagnostics and lab services tools at Nanogen, AltheaDx, Behring Diagnostics, and the Nichols Institute. Willig was general manager and chief commercial officer at Exiqon, vice president of global sales for Thermo Fisher's pathology business, and worked at Myriad Genetics and Abbott Diagnostics. Bradley has worked at Coherent Medical, Allergan, SenoRx, and at Vertos Medical.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.